おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Innate Pharma
company
About
Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- €15M
- Industries
- Biopharma,Biotechnology,Clinical Trials,Medical,Pharmaceutical
- Founded date
- Jan 1, 1999
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Innate Pharma S.A. is a biopharmaceutical company developing first-in-class immunotherapy drug candidates for cancer and inflammatory diseases.The Company specializes in the development of novel monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells. Its innovative approaches have led to licensing agreements with Novo Nordisk A/S and Bristol-Myers Squibb.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€97.60M
Innate Pharma has raised a total of
€97.60M
in funding over 2 rounds. Their latest funding was raised on
Oct 24, 2018 from a Corporate Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 24, 2018 | Corporate Round | €62.60M | 1 |
AstraZeneca
|
— | Detail |
| Sep 1, 2004 | Series C | €15M | 3 | — | — | Detail |
| Jan 1, 2002 | Series B | €20M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
4
Innate Pharma is funded by 4 investors.
AstraZeneca
and Novo Nordisk
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
AstraZeneca
|
Yes | Corporate Round |
Novo Nordisk
|
— | Series C |
Akka Venture
|
— | Series C |
NIF SMBC Ventures
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
